COVID-19 Myocardial Infarction Outcomes 
Coronary Artery Disease Journal
OCTOBER 23, 2023
Background Acute myocardial infarction (AMI) is one of the most lethal complications of COVID-19 hospitalization. In this study, we looked for the occurrence of AMI and its effects on hospital outcomes among COVID-19 patients. The odds of adverse outcomes such as mortality (aOR 3.90, 95% CI: 3.48–4.36),
Coronary Artery Disease Journal
OCTOBER 31, 2023
Background It is unclear how COVID-19 pandemic affected care and outcomes among patients who are diagnosed with ST-elevation myocardial infarction (STEMI) in the USA. Patients with COVID-19 versus those without had significantly greater in-hospital mortality (45.2% reduction in admissions in 2020.
Circulation: Cardiovascular Quality & Outcomes
JANUARY 19, 2024
Circulation: Cardiovascular Quality and Outcomes, Ahead of Print. Background:Type 2 myocardial infarction (T2MI) and type 1 myocardial infarction (T1MI) differ with respect to demographics, comorbidities, treatments, and clinical outcomes. 3.48]), and diagnoses of COVID-19 (odds ratio, 1.74 [95% CI, 1.11–2.71])
Open Heart
JUNE 24, 2022
Introduction COVID-19 may lead to long-term endothelial consequences including hypertension, stroke and myocardial infarction. mm Hg higher BP ≥12 weeks after recovery, compared with a group without COVID-19. mm Hg higher BP ≥12 weeks after recovery, compared with a group without COVID-19.
Open Heart
NOVEMBER 28, 2023
Eligible were all aetiological studies evaluating risk of cardiovascular outcomes after exposure to common RTIs within any follow-up duration. COVID-19 likely increases relative risk (RR (95% CI)) of myocardial infarction (3.3 (1.0 Other RTIs also likely increase the RR of myocardial infarction (2.9 (95%
Heart BMJ
MARCH 12, 2024
Objective To investigate whether a very early invasive strategy (IS)±revascularisation improves clinical outcomes compared with standard care IS in higher risk patients with non-ST-elevation acute coronary syndrome (NSTE-ACS). Results The trial was discontinued early by the funder due to slow recruitment during the COVID-19 pandemic.
Open Heart
FEBRUARY 4, 2025
Background Studies have shown an increased risk of cardiac disease following COVID-19, but how it compares to pneumonia of other etiologies is unclear. Aims To determine the incidence and HRs of cardiac disease in patients hospitalised with COVID-19 compared with other viral or bacterial pneumonias.
Expert insights. Personalized for you.
52 
Let's personalize your content